- Conditions
- Osteoarthritis, Blood Loss, Surgical, Blood Loss, Postoperative
- Interventions
- Tranexamic Acid (Oral), Tranexamic Acid (Intravenous)
- Drug
- Lead sponsor
- The New England Baptist Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 118 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 21, 2016 · Synced May 21, 2026, 11:55 PM EDT